News Archive - Page 21 of 131 - Life Sciences Scotland

Filter by Date

Clear

Pneumagen Announces £4m fundraising and Commits to Clinical Trial Development for COVID-19

neumagen (Holdings) Ltd, focused on treating infectious diseases by targeting the human glycome, today announced a GBP £4 million investment...

28th May 2020

National Manufacturing Institute Scotland leadership team bolstered with CEO appointment

The National Manufacturing Institute Scotland has announced that John Reid has been appointed as Chief Executive Officer to lead the...

28th May 2020

MGB Biopharma Announces Successful Outcome from Phase II Clinical Study with MGB-BP-3 – a Potential New Gold Standard, First-Line Treatment for Clostridium difficile Infection (CDI)

MGB Biopharma, a biopharmaceutical company developing a novel class of anti-infectives, today announces that its Phase II clinical study has...

26th May 2020

Amphista Therapeutics appoints leading protein degradation pioneer, Ian Churcher as CSO

Amphista Therapeutics, a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body’s natural processes to remove disease causing proteins...

21st May 2020

Onorach’s fighting COVID-19 portal goes live

The portal creates a register of interested parties for COVID19 clinical trials. The unprecedented global COVID-19 pandemic has put added...

15th May 2020

UK consortium launches COVID-19 Protein Portal to provide essential reagents for SARS-CoV-2 research

Launching today, Tuesday 12 May, the COVID-19 Protein Portal allows UK scientists to access protein reagents for critical research relating...

12th May 2020

Do you have news for the Scottish Life Sciences Community?

Submit Your Own News